Sign in
4

Changes in Ownership

Cartesian Therapeutics, Inc. Filed Acc 0001453687-20-000021

President and CEO sold 3,374 shares at $3.86 ($13,011)

  • President and CEO acquired 10,937 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Brunn Carsten · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-03-01 Exercise or conversion : show line 1 in the form +10,937 81,851 D
2020-03-03 Sale : show line 2 in the form −3,374 $3.86 $13,011 78,477 D
Open-market sales · 3,374 sh · avg $3.86 · $13,011

Table II: Derivative

1 line
Date Transaction Shares Underlying Owned after D/I
2020-03-01 Exercise or conversion : show line 3 in the form Restricted Stock Units −10,937 10,937 120,313 D
Loading xslF345X03/wf-form4_158327072572666.xml…